Alessandra Tedeschi, MD, is consultant in Hematology at the Department  of Hematology  Niguarda  Hospital in Milano, Italy. Dr Tedeschi  received her medical degree from the  University Medical School in Bologna  and subsequently trained in hemato-oncology in the Hematology Institute at Ancona University Medical School. From 1996 to 1999 she completed research stages on cord blood transplantation and low grade lymphomas at  the Department  of Hematology  Niguarda Hospital Milano, Italy and Chronic Lymphocytic Leukemia at the Leukemia Section of MD Anderson Cancer Center Houston, Texas.

In 1999 she joined the staff as consultant in Hematology  at the Department  of Hematology,  Niguarda  Cancer Centrer, Niguarda  Hospital in Milano.

Doctor Tedeschi main research interests focus on novel treatment approaches in hematological malignancies, most notably in  Chronic Lymphocytic Leukaemia and Waldenstrom’s Macropglobulinemia.

She is principal and co-investigator of many National and International trials in chronic lymphoprolipherative disorders. Dr Tedeschi is a member of European Research Initiative for Chronic Lymphocytic Leukemia, European hematolology Association and the European Waldenstrom Macroglobulinemia Network.  Additionaly she has co-authored the response criteria and ESMO guidelines on  Waldenstrom’s Macroglobulinemia. She has published over 100 scientific papers in International peer-reviewed journals including New England Journal of Medicine, Journal Clinical Oncology, Blood , Leukemia.